Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a random...
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
About this item
Full title
Author / Creator
Khatri, Bhupendra, Dr , Barkhof, Frederik, MD , Comi, Giancarlo, MD , Hartung, Hans-Peter, MD , Kappos, Ludwig, MD , Montalban, Xavier, MD , Pelletier, Jean, MD , Stites, Tracy, PhD , Wu, Stacy, MD , Holdbrook, Fred, PhD , Zhang-Auberson, Lixin, MD , Francis, Gordon, MD , Cohen, Jeffrey A, MD , on behalf of the TRANSFORMS Study Group and TRANSFORMS Study Group
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background In a 12-month phase 3 study in patients with relapsing-remitting multiple sclerosis (RRMS), TRANSFORMS, fingolimod showed greater efficacy on relapse rates and MRI outcomes compared with interferon beta-1a. We had two aims in our extension: to compare year 2 with year 1 in the switched patients to assess the effect of a change fr...
Alternative Titles
Full title
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
Authors, Artists and Contributors
Author / Creator
Barkhof, Frederik, MD
Comi, Giancarlo, MD
Hartung, Hans-Peter, MD
Kappos, Ludwig, MD
Montalban, Xavier, MD
Pelletier, Jean, MD
Stites, Tracy, PhD
Wu, Stacy, MD
Holdbrook, Fred, PhD
Zhang-Auberson, Lixin, MD
Francis, Gordon, MD
Cohen, Jeffrey A, MD
on behalf of the TRANSFORMS Study Group
TRANSFORMS Study Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_876247718
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_876247718
Other Identifiers
ISSN
1474-4422
E-ISSN
1474-4465
DOI
10.1016/S1474-4422(11)70099-0
